Danaher Corporation
DHR · NYSE194.98
194.98
USD-0.66-0.33%Дата
Тікери
Заголовок
Джерело
Danaher nears $10B acquisition of medical tech company Masimo, FT reports
SeekingAlpha
Danaher closes in on nearly $10bn deal for medical device maker Masimo - Financial Times
Financial Times
Agilent, Danaher could be potential buyers of Qiagen - analyst
SeekingAlpha
Nvidia gives up gains — plus, what's behind another rough day for Danaher
CNBC
Here's why Danaher shares fell 4% on Thursday — a week after hitting record highs
CNBC
Cramer says Danaher is a buy and weighs in on probes of Microsoft and Nvidia
CNBC
What's behind Danaher's decline, plus high hopes for Apple's developers event
CNBC
Danaher shares hit a 1-year high after earnings and we're increasing our price target
CNBC
Danaher's new acquisition is the latest sign the health-care firm is staging a quiet recovery
CNBC
How Danaher's new acquisition will boost earnings for the life sciences firm
CNBC
Abcam gains after securing all approvals for Danaher sale, set to close Dec. 6
SeekingAlpha
Abcam ticks higher amid report of China approval for sale to Danaher
SeekingAlpha
Shareholders of Abcam approve proposed acquisition by Danaher
SeekingAlpha
Why we bought more Danaher even after it lowered the forecast for a key business
CNBC
Abcam holders should vote for sale to Danaher, proxy adviser ISS says
SeekingAlpha
Abcam founder looking at various options amid Danaher takeover - report
SeekingAlpha
Abcam holder, founder Jonathan Milner opposes Danaher acquisition
SeekingAlpha
Abcam ticks higher as founder Milner says Danaher deal undervalues company
SeekingAlpha
Abcam founder, holder Jonathan Milner still evaluating Danaher deal - report
SeekingAlpha
Abcam holder Milner expects to speak to holders next week on Danaher deal - report
SeekingAlpha
Danaher agrees to buy Abcam for $24 a share in cash
SeekingAlpha
Abcam gains on reports Danaher in lead to acquire company
SeekingAlpha
Danaher cut its outlook for 2023, but we're maintaining our rating — here's why
CNBC
Abcam gains on report it's seeing takeover interest from Danaher, Agilent
SeekingAlpha
First Republic deal boosts our banks. Danaher gets a confidence vote. Here are our takes on the news
CNBC
Catalent ticks higher amid speculation Danaher still interested in deal
SeekingAlpha
Danaher's disappointing guidance weighs on the stock — and forces us to reassess our investment case
CNBC
#earnings for the week https://t.co/lObOE0dgsr $AMZN $MSFT $META $FRC $KO $BA $VZ $GOOGL $UPS $ENPH $CLF $HAL $MCD $GM $GE $MMM $PEP $XOM $SPOT $INTC $AAL $V $ROKU $RTX $NEE $PHG $CAT $CVX $SNAP $LLY $VLO $LUV $BOH $MA $CROX $SIFY $JBLU $CMG $DOW $MO $ABBV $NOW $DHR $DX $NET… https://t.co/XwpWMeSZbn
Club meeting recap: Stocks fall, Emerson upgrade, Danaher readthrough
CNBC
Catalent falls on report Danaher said to end pursuit
SeekingAlpha
Jim Cramer's Investing Club meeting Thursday: Jobs report, Danaher, Honeywell
CNBC
Why did Catalent stock soar today? Potential takeover by Danaher
SeekingAlpha
Coterra, Danaher and TJX Companies are in the news. Here's our take on the headlines
CNBC
Catalent climbs 22% on Danaher interest as Jefferies sees $93/share deal
SeekingAlpha
Danaher said to be interested in acquiring contract manufacturer Catalent
SeekingAlpha
Jim Cramer's Investing Club meeting Tuesday: J&J, Danaher, AMD
CNBC
Cramer's lighting round: I like Danaher over Philips
CNBC
What Cramer is watching Monday — Fed pivot, Xi consolidates, DHR and META downgrades
CNBC
Danaher shares slide after knockout quarter. Here's why it's a buying opportunity
CNBC
2 takeaways from our daily meeting: Semiconductors, Danaher's earnings beat
CNBC
What Cramer is watching Thursday — Tesla slides, IBM surprises, Danaher rolls on
CNBC
What the Club is watching Friday — social media clobbered, Danaher's target hike
CNBC
Danaher maneuvers through tangled supply chain to make great quarterly earnings
CNBC
Часті питання
На що чекаєте?Почніть заробляти прибуток сьогодні
Інструменти
Ринки
Більше
Ресурси
Порівняти
Мобільний додаток для отримання прибутку
Відкрийте світ фінансів у вашому кишені
©
2026
Всі права захищені